Window of hope in cancer fight


Researchers based in Delhi find that arthritis drug may inhibit a key bacterium

A new treatment option for stomach cancer may be in the offing. Researchers from the School of Life Sciences and Special Centre for Molecular Medicine at Jawaharlal Nehru University (JNU), New Delhi, have found that the anti-arthritis drug diflunisal can be used to kill Helicobacter pylori, a bacterium responsible for stomach-related problems ranging from chronic gastritis and ulcers to cancer.

A common cancer

The development assumes importance as stomach cancer is the second-most common cancer among men and third-most among women worldwide...................Read more

 

Source: The Hindu


Comments (0)



Please Login or Register to join groups